Literature DB >> 29506125

The future of continuing medical education: the roles of medical professional societies and the health care industry.

.   

Abstract

In recent years, wide ranging biomedical innovation has provided powerful new approaches for prevention, diagnosis and management of diseases. In order to translate such innovation into effective practice, physicians must frequently update their knowledge base and skills through continuing medical education and training. Medical Professional Societies, run as not-for-profit organizations led by peers, are uniquely placed to deliver balanced, disease oriented and patient centred education. The medical industry has a major role in the development of new, improved technology, devices and medication. In fact, the best innovations have been achieved through collaboration with scientists, clinical academics and practicing physicians. Industry has for many years been committed to ensure the optimal and safe application of its products by providing unrestricted support of medical education developed and delivered by international and national learned societies. Recently adopted Codes of Practice for the Pharmaceutical and Device industry were intended to enhance public trust in the relationship between biomedical industry and physicians. Unexpectedly, changes resulting from adoption of the Codes have limited the opportunity for unconditional industry support of balanced medical education in favour of a more direct involvement of industry in informing physicians about their products. We describe the need for continuing medical education in Cardiovascular Medicine in Europe, interaction between the medical profession and medical industry, and propose measures to safeguard the provision of high quality, balanced medical education. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Conflict of interest; Continuing professional development; Health care industry; Medical education; Professional societies; Training in cardiovascular medicine

Mesh:

Year:  2019        PMID: 29506125     DOI: 10.1093/eurheartj/ehy003

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

Review 1.  Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project.

Authors:  Ricardo Lopez Santi; Felipe Martinez; Adrian Baranchuk; Alvaro Sosa Liprandi; Daniel Piskorz; Alberto Lorenzatti; Maria Pilar Lopez Santi; Juan Carlos Kaski
Journal:  Eur Cardiol       Date:  2021-04-27

Review 2.  Evolving role of pharmaceutical physicians in medical evidence and education.

Authors:  Sajita Setia; Nicola J Ryan; Prasad S Nair; Elma Ching; Kannan Subramaniam
Journal:  Adv Med Educ Pract       Date:  2018-11-02

3.  Massive open online courses (MOOCs) for continuing medical education - why and how?

Authors:  Sajita Setia; Jam Chin Tay; Yook Chin Chia; Kannan Subramaniam
Journal:  Adv Med Educ Pract       Date:  2019-09-11

4.  Continuing medical education and work commitment among rural healthcare workers: a cross-sectional study in 11 western provinces in China.

Authors:  Jinlin Liu; Ying Mao
Journal:  BMJ Open       Date:  2020-08-04       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.